Shattuck Labs(STTK)
AUSTIN, TXBiotechnology
Focus: Shattuck Labs is a public immunotherapy platform company focused on oncology, leveraging a proprietary technology approach to develop novel cancer treatments. The company is early-stage with minimal revenue and operates from Austin, TX.
Profile data last refreshed 2h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
1
Should You Work at Shattuck Labs?
AI assessmentHigh-risk, high-upside early-stage bet suited only for scientists and translational professionals comfortable with clinical stage uncertainty and willing to weather potential financing events or pivots.
Why Work Here
- Early-stage oncology immunotherapy platform with multiple indications for a lead program (SL-172154 in ovarian cancer, cutaneous squamous cell carcinoma, and AML) offering broad exposure to clinical development
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$6M
Pipeline & Clinical Trials
SL-172154
Ovarian CancerClinical Trials (1)
NCT04406623Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer
Phase 1Help build intelligence for Shattuck Labs
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.